Logo-bi
Bioimpacts. 2023;13(1): 17-29. doi: 10.34172/bi.2022.23682
PMID: 36816996        PMCID: PMC9923814

Original Research

Synthesis and characterization of actively HER-2 Targeted Fe3O4@Au nanoparticles for molecular radiosensitization of breast cancer

Behnaz Babaye Abdollahi 1,2 ORCID, Marjan Ghorbani 3, Hamed Hamishehkar 1, Reza Malekzadeh 2, Alireza Farajollahi 1,2,4 * ORCID

Cited by CrossRef: 15

1- Firouzi Amandi A, Bahmanyar Z, Dadashpour M, Lak M, Natami M, Döğüş Y, Alem M, Adeli O. Fabrication of magnetic niosomal platform for delivery of resveratrol: potential anticancer activity against human pancreatic cancer Capan-1 cell. Cancer Cell Int. 2024;24(1) [Crossref]
2- Dastgir M, Ayyami Y, Pourfarshid A, Ghorbani M, Mortezazadeh T. Evaluation of the theranostic characteristics of chitosan-decorated bismuth oxide nanoparticles conjugated curcumin and 5-aminolevulinic acid as a biocompatible targeted nanoplatform in CT and breast cancer radiation therapy. Journal of Drug Delivery Science and Technology. 2024;92:105279 [Crossref]
3- Alipour B, Alvandi V, Mehrabifard M, Talaee O, Zamani H, Tabatabayi F, Malekzadeh R, Mortezazadeh T. Advances in nano-scale metal-based contrast agents for computed tomography: A systematic review. Radiation Physics and Chemistry. 2025;226:112195 [Crossref]
4- Bhat A, Gupta G, Afzal M, Thapa R, Ali H, Alqahtani S, almalki W, Kazmi I, Alzarea S, Saleem S, Subramaniyan V. Polyphenol-Loaded Nano-carriers for Breast Cancer Therapy: A Comprehensive Review. BioNanoSci. 2024;14(4):4219 [Crossref]
5- Wang Y, Liu X, Ma S, He X, Guo C, Liang Z, Hu Y, Wei Y, Lian X, Huang D. Progress in cancer therapy with functionalized Fe3O4 nanomaterials. Front Mater Sci. 2023;17(3) [Crossref]
6- Talaee O, Faghihi R, Rastegari B, Sina S. Enhanced radio-photodynamic therapy potential of advanced gold-based nanoclusters for breast cancer treatment. Radiol Phys Technol. 2024;17(3):703 [Crossref]
7- Ziyaee S, Malekzadeh R, Ghorbani M, Nasiri Motlagh B, Asghariazar V, Mortezazadeh T. Preparation of MnO2@poly-(DMAEMA-co-IA)-conjugated methotrexate nano-complex for MRI and radiotherapy of breast cancer application. Magn Reson Mater Phy. 2023;36(5):779 [Crossref]
8- Ayyami Y, Ghorbani M, Dastgir M, Malekzadeh R, Mortezazadeh T. Chitosan-modified manganese oxide-conjugated methotrexate nanoparticles delivering 5-aminolevulinic acid as a dual-modal T1–T2* MRI contrast agent in U87MG cell detection. Magn Reson Mater Phy. 2024;37(5):909 [Crossref]
9- Mansouri E, Mesbahi A, Hamishehkar H, Montazersaheb S, Hosseini V, Rajabpour S. The effect of nanoparticle coating on biological, chemical and biophysical parameters influencing radiosensitization in nanoparticle-aided radiation therapy. BMC Chemistry. 2023;17(1) [Crossref]
10- Alipour B, Mortezazadeh T, Abdulsahib W, Arzhang A, Malekzadeh R, Farhood B. A systematic review of multimodal application of quantum dots in breast cancer diagnosis: Effective parameters, status and future perspectives. Journal of Drug Delivery Science and Technology. 2023;86:104682 [Crossref]
11- Slama Y, Arcambal A, Septembre-Malaterre A, Morel A, Pesnel S, Gasque P. Evaluation of core-shell Fe3O4@Au nanoparticles as radioenhancer in A549 cell lung cancer model. Heliyon. 2024;10(8):e29297 [Crossref]
12- Ayyami Y, Dastgir M, Ghorbani M, Jangjoo A, Pourfarshid A, Malekzadeh R, Mortezazadeh T. Characterization and application of targeted MnO2/CS@ALA-MTX nano-radiosensitizers for boosting X-ray radiotherapy of brain tumors. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2024;692:133975 [Crossref]
13- Malekzadeh R, Mortezazadeh T, Abdulsahib W, Babaye abdollahi B, Hamblin M, Mansoori B, Alsaikhan F, Zeng B. Nanoarchitecture-based photothermal ablation of cancer: A systematic review. Environmental Research. 2023;236:116526 [Crossref]
14- Chehelgerdi M, Chehelgerdi M, Allela O, Pecho R, Jayasankar N, Rao D, Thamaraikani T, Vasanthan M, Viktor P, Lakshmaiya N, Saadh M, Amajd A, Abo-Zaid M, Castillo-Acobo R, Ismail A, Amin A, Akhavan-Sigari R. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol Cancer. 2023;22(1) [Crossref]
15- Arcambal A, Septembre-Malaterre A, Pesnel S, Morel A, Gasque P, Begue M, Slama Y. The Potential of Human Pulmonary Mesenchymal Stem Cells as Vectors for Radiosensitizing Metallic Nanoparticles: An In Vitro Study. Cancers. 2024;16(18):3239 [Crossref]

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge